RASSF5 (RAS association domain family member 5): The combination of RASSF5 along with four other DNA methylation markers can effectively differentiate between benign prostate biopsy cores from non-cancer patients and cancer cores, and can be used to identify patients at risk without repeat biopsies (Brikun et al., 2014). The gene discussed is RASSF5; the disease is cancer.